Journal Article (Review Article)

DKFZ-2026-00786

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png Long-term organ toxicity of oncological therapies. [Langzeit-Organtoxizität von onkologischen Therapien].

Thong, M. (First author)DKFZ* ; Doege, D.DKFZ* ; Frick, J.DKFZ* ; Arndt, V. (Last author)DKFZ*

2026
Thieme Stuttgart [u.a.]

Abstract: Increasing survival rates following cancer diagnoses, combined with demographic aging, have resulted in a growing population of long-term survivors. Many of these individuals face persistent and late-onset effects of oncological treatments. This article examines the most common sequelae associated with traditional treatment approaches, presents emerging evidence on innovative therapies, and explores their impact on patients' quality of life.

Keyword(s): Humans (MeSH) ; Quality of Life: psychology (MeSH) ; Neoplasms: therapy (MeSH) ; Long Term Adverse Effects (MeSH) ; Antineoplastic Agents: adverse effects (MeSH) ; Cancer Survivors (MeSH) ; Antineoplastic Agents

Note: #EA:C071#LA:C071#

---

Contributing Institute(s):

1. Cancer Survivorship (C071)

Research Program(s):

1. 313 - Krebsrisikofaktoren und Prävention (POF4-313) (POF4-313)

Appears in the scientific report 2026

---

Database coverage:
; Clarivate Analytics Master Journal List ; Current Contents - Clinical Medicine ; Essential Science Indicators ; IF < 5 ; JCR ; Nationallizenz ; SCOPUS ; Science Citation Index Expanded ; Web of Science Core Collection

---